why choose us

First received: May 12, 2023

Clinical Trial: Study of VXCO-100, a SARS-CoV Candidate Vaccine in Healthy Adults in the United States

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: SARS-CoV

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of VXCO-100 in Healthy Adults in the United States

Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of ascending dose levels of VXCO-100 in healthy adults.

Read more